🚀 VC round data is live in beta, check it out!
- Public Comps
- Savaria
Savaria Valuation Multiples
Discover revenue and EBITDA valuation multiples for Savaria and similar public comparables like C Sun Manufacturing, Pulse Biosciences, thyssenkrupp nucera, Vitrolife and more.
Savaria Overview
About Savaria
Savaria Corp designs, engineers, and manufactures products for personal mobility. Its products include home elevators, wheelchair lifts, commercial elevators, ceiling lifts, stairlifts, and van conversions. The company's operating segments are Accessibility and Patient Care. The Accessibility segment deals with manufacturing, designing, installing, and distributing elevators, platform lifts, and stairlifts for people with mobility challenges. The Patient Care segment includes the manufacturing and distribution of a comprehensive line of therapeutic support surfaces and other pressure management products for the medical market. It derives maximum revenue from Accessibility segment.
Founded
1999
HQ

Employees
2.4K
Website
Sectors
Financials (LTM)
EV
$1B
Savaria Financials
Savaria reported last 12-month revenue of $675M and EBITDA of $139M.
In the same LTM period, Savaria generated $260M in gross profit, $139M in EBITDA, and $55M in net income.
Savaria P&L
In the most recent fiscal year, Savaria reported revenue of $668M and EBITDA of $136M.
Savaria expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $675M | XXX | $668M | XXX | XXX | XXX |
| Gross Profit | $260M | XXX | $255M | XXX | XXX | XXX |
| Gross Margin | 39% | XXX | 38% | XXX | XXX | XXX |
| EBITDA | $139M | XXX | $136M | XXX | XXX | XXX |
| EBITDA Margin | 21% | XXX | 20% | XXX | XXX | XXX |
| EBIT Margin | 13% | XXX | 13% | XXX | XXX | XXX |
| Net Profit | $55M | XXX | $50M | XXX | XXX | XXX |
| Net Margin | 8% | XXX | 8% | XXX | XXX | XXX |
| Net Debt | — | — | $97M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Savaria Stock Performance
Savaria has current market cap of $1B, and enterprise value of $1B.
Savaria's stock price is $18.13.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1B | $1B | -0.3% | XXX | XXX | XXX | $0.70 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialSavaria Valuation Multiples
Savaria trades at 2.1x EV/Revenue multiple, and 10.4x EV/EBITDA.
Savaria Financial Valuation Multiples
As of March 29, 2026, Savaria has market cap of $1B and EV of $1B.
Equity research analysts estimate Savaria's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Savaria has a P/E ratio of 23.5x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1B | XXX | $1B | XXX | XXX | XXX |
| EV (current) | $1B | XXX | $1B | XXX | XXX | XXX |
| EV/Revenue | 2.1x | XXX | 2.2x | XXX | XXX | XXX |
| EV/EBITDA | 10.4x | XXX | 10.6x | XXX | XXX | XXX |
| EV/EBIT | 16.5x | XXX | 17.3x | XXX | XXX | XXX |
| EV/Gross Profit | 5.6x | XXX | 5.7x | XXX | XXX | XXX |
| P/E | 23.5x | XXX | 25.8x | XXX | XXX | XXX |
| EV/FCF | 20.1x | XXX | 17.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Savaria Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Savaria Margins & Growth Rates
Savaria's revenue in the last 12 month grew by 5%.
Savaria's revenue per employee in the last FY averaged $0.3M.
Savaria's rule of 40 is 25% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Savaria's rule of X is 33% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Savaria Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 5% | XXX | 4% | XXX | XXX | XXX |
| EBITDA Margin | 21% | XXX | 20% | XXX | XXX | XXX |
| EBITDA Growth | 8% | XXX | 7% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 25% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 33% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.3M | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 26% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 26% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Savaria Public Comps
See public comps and valuation multiples for other Medical Devices and Machinery comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| C Sun Manufacturing | XXX | XXX | XXX | XXX | XXX | XXX |
| Pulse Biosciences | XXX | XXX | XXX | XXX | XXX | XXX |
| thyssenkrupp nucera | XXX | XXX | XXX | XXX | XXX | XXX |
| Vitrolife | XXX | XXX | XXX | XXX | XXX | XXX |
| Subgen AI | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Savaria M&A Activity
Savaria acquired XXX companies to date.
Last acquisition by Savaria was on XXXXXXXX, XXXXX. Savaria acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Savaria
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialSavaria Investment Activity
Savaria invested in XXX companies to date.
Savaria made its latest investment on XXXXXXXX, XXXXX. Savaria invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Savaria
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Savaria
| When was Savaria founded? | Savaria was founded in 1999. |
| Where is Savaria headquartered? | Savaria is headquartered in Canada. |
| How many employees does Savaria have? | As of today, Savaria has over 2K employees. |
| Is Savaria publicly listed? | Yes, Savaria is a public company listed on Tokyo Stock Exchange. |
| What is the stock symbol of Savaria? | Savaria trades under SIS ticker. |
| When did Savaria go public? | Savaria went public in 2003. |
| Who are competitors of Savaria? | Savaria main competitors are C Sun Manufacturing, Pulse Biosciences, thyssenkrupp nucera, Vitrolife. |
| What is the current market cap of Savaria? | Savaria's current market cap is $1B. |
| What is the current revenue of Savaria? | Savaria's last 12 months revenue is $675M. |
| What is the current revenue growth of Savaria? | Savaria revenue growth (NTM/LTM) is 5%. |
| What is the current EV/Revenue multiple of Savaria? | Current revenue multiple of Savaria is 2.1x. |
| Is Savaria profitable? | Yes, Savaria is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Savaria? | Savaria's last 12 months EBITDA is $139M. |
| What is Savaria's EBITDA margin? | Savaria's last 12 months EBITDA margin is 21%. |
| What is the current EV/EBITDA multiple of Savaria? | Current EBITDA multiple of Savaria is 10.4x. |
| What is the current FCF of Savaria? | Savaria's last 12 months FCF is $72M. |
| What is Savaria's FCF margin? | Savaria's last 12 months FCF margin is 11%. |
| What is the current EV/FCF multiple of Savaria? | Current FCF multiple of Savaria is 20.1x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.